, Tracking Stock Market Picks
Enter Symbol:
Abbott Laboratories (ABT) [hlAlert]

down 14.51 %

Abbott Laboratories (ABT) rated Outperform with price target $62 by Wedbush Morgan

Posted on: Thursday,  Nov 12, 2009  9:25 AM ET by Wedbush Morgan

Wedbush Morgan rated Outperform Abbott Laboratories (NYSE: ABT) on 11/12/2009, when the stock price was $53.39. Since
then, Abbott Laboratories has lost 14.52% as of 10/07/2015's recent price of $45.64.
If you would have followed this Wedbush Morgan's recommendation on ABT, you would have lost 14.51% of your investment in 2155 days.

Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles life itself addressing important health needs from infancy to the golden years.

Since 1980, WEDBUSH has used its private equity discipline to invest in under-valued and capital constrained public and private companies that have a significant potential for appreciation. The firm invests with high quality management teams with domain expertise and expects management to retain or make a personally significant equity investment.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2009 9:25 AM Buy
53.39 62.00
as of 12/31/2009
1 Week down  -11.50 %
1 Month down  -12.05 %
3 Months down  -10.24 %
1 YTD down  -10.24 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy